Important Information for uniQure Investors Regarding Class Action Lawsuit by Levi & Korsinsky

Call to Action for uniQure Investors: Class Action Notice

Investors holding shares in uniQure N.V. (NASDAQ: QURE) are advised of a significant class action securities lawsuit led by Levi & Korsinsky, LLP. This notice serves as an essential alert for all affected parties who faced losses due to alleged misconduct by the company during a marked timeframe between September 24, 2025, and October 31, 2025.

Overview of the Lawsuit

The class action aims to recover financial losses for uniQure investors adversely impacted by claims of securities fraud. The allegations suggest that the company made misleading statements or omitted crucial facts regarding their pivotal study’s design and outcomes. Specifically, the lawsuit argues that:
1. The design of the pivotal study, which included the comparison of results to an external data set, was not fully sanctioned by the FDA.
2. There was a minimization of the likelihood that, contrary to claims of successful results, uniQure would have to delay its Biologics License Application (BLA) to conduct additional studies.
3. Statements about uniQure's business and operational future lacked a reasonable foundation due to these issues.

Key Dates and Participation Requirements

Anyone who suffered a financial setback in their investment within the specified period has until April 13, 2026, to notify the court of their intent to participate as a lead plaintiff. It is important for potential claimants to understand that even if they choose not to become lead plaintiffs, they may still be eligible to share in any financial recovery resulting from the lawsuit.

Involvement in this class action will not incur any costs, ensuring that the process is accessible to all impacted investors without financial barriers. This means that class members who are accepted into the lawsuit may receive compensation without any upfront fees.

About Levi & Korsinsky, LLP

The firm of Levi & Korsinsky boasts over two decades of experience representing unhappy shareholders and has achieved recoveries totaling hundreds of millions of dollars. Their established reputation in high-stakes litigation is reinforced by consistently ranking among the top firms in the U.S. for securities class action cases according to ISS Securities Class Action Services.

The firm has over seventy specialized staff dedicated to serving clients, ensuring thorough and competent representation throughout the legal process. Investors can contact Joseph E. Levi, Esq. or Ed Korsinsky, Esq. at Levi & Korsinsky for inquiries or assistance in submitting claims.

Contact Information

For more information on how to participate in this class action, affected investors can reach out to Levi & Korsinsky through the following:

It is crucial for anyone invested in uniQure during the specified timeframe to consider this opportunity seriously. The implications of the lawsuit could lead to significant financial recoveries for those affected by the alleged securities fraud.